Shares of Dishman Pharmaceuticals and Chemicals may see buying interest on Tuesday on positive outlook from a rating agency.

The pharma major informed the bourses that India Rating and Research Pvt Ltd has revised the outlook to ‘positive’ from ‘stable’ for its long-term/fund-based facilities and non-convertible debenture issues. It has, however, reaffirmed its rating at ‘Ind A’ for (term loans & NCDs) and ‘Ind A1’ for short-term facilities

comment COMMENT NOW